Literature DB >> 28537809

Association of Three Single Nucleotide Polymorphisms in MTR and MTRR Genes with Lung Cancer in a Turkish Population.

Pinar Aksoy-Sagirli1, Ayçin Erdenay1, Esra Kaytan-Saglam2, Ahmet Kizir3.   

Abstract

AIMS: Folate metabolism plays a critical role in DNA methylation and synthesis. Polymorphisms in folate metabolism may affect enzyme activities and thereby affect the cancer risk. Methionine synthase (MTR) and methionine synthase reductase (MTRR) are critical enzymes for the folate cycle. In this study, possible associations between genetic variabilities in MTR and MTRR and susceptibility to lung cancer (LC) were investigated in a Turkish population.
METHODS: A case-control study with 193 LC cases and 199 noncancerous controls was conducted. DNA was extracted from leukocytes using the high pure polymerase chain reaction (PCR) template preparation kit. The MTR 2756 A>G (rs1805087), MTRR 524 C > T (rs1532268), and MTRR 66 A>G (rs1801394) genotypes were determined using PCR-restriction fragment length polymorphism (PCR-RFLP) assays. The genotype and haplotype analyses of these polymorphisms were performed using SPSS 21 and Haploview 4.2, respectively.
RESULTS: An association between the MTRR A66G polymorphism and LC (p = 0.042) was found. In addition, this allele was observed more frequently in smokers compared to nonsmokers (p = 0.030). In contrast, the distribution of the MTR 2756 A>G and the MTRR 524 C > T allele frequencies were similar in the subject cases and controls.
CONCLUSIONS: In conclusion, the present study suggests an association between the MTRR 66 A>G gene polymorphisms and LC risk in a Turkish population.

Entities:  

Keywords:  folate cycle; lung cancer; methionine synthase; methionine synthase reductase; polymorphism

Mesh:

Substances:

Year:  2017        PMID: 28537809     DOI: 10.1089/gtmb.2017.0062

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  8 in total

1.  Post Genome-Wide Gene-Environment Interaction Study Using Random Survival Forest: Insulin Resistance, Lifestyle Factors, and Colorectal Cancer Risk.

Authors:  Su Yon Jung; Jeanette C Papp; Eric M Sobel; Zuo-Feng Zhang
Journal:  Cancer Prev Res (Phila)       Date:  2019-09-25

2.  Genetic variants in RUNX3, AMD1 and MSRA in the methionine metabolic pathway and survival in nonsmall cell lung cancer patients.

Authors:  Ka Chen; Hongliang Liu; Zhensheng Liu; Sheng Luo; Edward F Patz; Patricia G Moorman; Li Su; Sipeng Shen; David C Christiani; Qingyi Wei
Journal:  Int J Cancer       Date:  2019-02-01       Impact factor: 7.396

3.  A regulation probability model-based meta-analysis of multiple transcriptomics data sets for cancer biomarker identification.

Authors:  Xin-Ping Xie; Yu-Feng Xie; Hong-Qiang Wang
Journal:  BMC Bioinformatics       Date:  2017-08-23       Impact factor: 3.169

Review 4.  A single-nucleotide polymorphism (rs1805087) in the methionine synthase (METH) gene increases the risk of prostate cancer.

Authors:  Xiaosong Zhang; Jilei Tang; Nan Shen; Kewei Ren
Journal:  Aging (Albany NY)       Date:  2018-10-18       Impact factor: 5.682

5.  Association study between genetic polymorphisms in folate metabolism and gastric cancer susceptibility in Chinese Han population: A case-control study.

Authors:  Lusha Wei; Fanglin Niu; Jiamin Wu; Fulin Chen; Hua Yang; Jing Li; Tianbo Jin; Yifei Wu
Journal:  Mol Genet Genomic Med       Date:  2019-03-18       Impact factor: 2.183

6.  Post genome-wide gene-environment interaction study: The effect of genetically driven insulin resistance on breast cancer risk using Mendelian randomization.

Authors:  Su Yon Jung; Nicholas Mancuso; Jeanette Papp; Eric Sobel; Zuo-Feng Zhang
Journal:  PLoS One       Date:  2019-06-27       Impact factor: 3.240

7.  The association between MTHFR polymorphism and cervical cancer.

Authors:  Jiao-Mei Gong; Yong Shen; Wan-Wan Shan; Yan-Xia He
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

8.  Mendelian Randomization Study: The Association Between Metabolic Pathways and Colorectal Cancer Risk.

Authors:  Su Yon Jung; Jeanette C Papp; Eric M Sobel; Zuo-Feng Zhang
Journal:  Front Oncol       Date:  2020-07-23       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.